| P50 | author | Rolf Adolfsson | Q44078623 |
| P2093 | author name string | Karl-Fredrik Norrback | |
| | Pontus Karling | |
| | Mikael Wikgren | |
| | Martin Maripuu | |
| P2860 | cites work | Revisiting the Dexamethasone Suppression Test in unipolar major depression: an exploratory study | Q21203924 |
| | Psychosocial Disability in the Course of Bipolar I and II Disorders | Q22253033 |
| | Quality of life in bipolar disorder: a review of the literature | Q25257218 |
| | An Inventory for Measuring Depression | Q26778503 |
| | Psychiatric complications of treatment with corticosteroids: review with case report | Q27021978 |
| | Stress and disorders of the stress system | Q28247137 |
| | If it goes up, must it come down? Chronic stress and the hypothalamic-pituitary-adrenocortical axis in humans | Q28281673 |
| | Lithium monotherapy increases ACTH and cortisol response in the DEX/CRH test in unipolar depressed subjects. A study with 30 treatment-naive patients | Q28478124 |
| | A New Depression Scale Designed to be Sensitive to Change | Q29614720 |
| | A meta-analysis of cytokines in major depression | Q29617325 |
| | An inventory for measuring clinical anxiety: psychometric properties | Q29619838 |
| | Tissue-specific dysregulation of cortisol metabolism in human obesity | Q32132870 |
| | The brief scale for anxiety: a subdivision of the comprehensive psychopathological rating scale | Q33620247 |
| | The potential role of hypocortisolism in the pathophysiology of stress-related bodily disorders | Q33816283 |
| | Corticosteroid-induced adverse psychiatric effects: incidence, diagnosis and management. | Q33836469 |
| | Historical perspectives and natural history of bipolar disorder | Q33920209 |
| | Psychiatric disorders associated with Cushing's syndrome. Epidemiology, pathophysiology and treatment | Q34085255 |
| | Corticosteroid receptor mediated effects on mood in humans | Q34412429 |
| | Psychosomatic aspects of Cushing's disease | Q34749383 |
| | Effects of glucocorticoids on mood, memory, and the hippocampus. Treatment and preventive therapy | Q35012406 |
| | Emerging experimental therapeutics for bipolar disorder: clues from the molecular pathophysiology | Q35770190 |
| | Bipolar depression: the real challenge | Q35772877 |
| | Hypothalamic-pituitary-adrenal axis and bipolar disorder. | Q36096503 |
| | A new view on hypocortisolism | Q36159874 |
| | Burden of bipolar depression: impact of disorder and medications on quality of life | Q37133288 |
| | Drugs and HPA axis. | Q37135438 |
| | Late-life depressive symptoms are associated with both hyperactivity and hypoactivity of the hypothalamo-pituitary-adrenal axis | Q37172182 |
| | Status of glucocorticoid alterations in post-traumatic stress disorder | Q37631137 |
| | Psychosomatic aspects of Cushing's syndrome | Q37644244 |
| | Quality of life: the ultimate outcome measure of interventions in major depressive disorder | Q37931992 |
| | Glucocorticoid sensitivity in mood disorders | Q37955011 |
| | Health-related quality of life in bipolar disorder | Q37983600 |
| | Is there a measurement overlap between depressive symptoms and quality of life? | Q39937511 |
| | The dexamethasone suppression test for melancholia | Q40342019 |
| | A comprehensive psychopathological rating scale | Q40543557 |
| | Axis V--Global Assessment of Functioning Scale. Evaluation of a self-report version | Q41013795 |
| | The dexamethasone suppression test in patients with mood disorders. | Q41203480 |
| | The corticotropin-releasing factor (CRF) hypothesis of depression: new findings and new directions. | Q41445105 |
| | Association between response to lithium augmentation and the combined DEX/CRH test in major depressive disorder | Q42167248 |
| | Urinary free cortisol excretion in elderly persons with minor and major depression | Q43766110 |
| | Depression and hypothalamic-pituitary-adrenal activation: a quantitative summary of four decades of research | Q43789984 |
| | Tissue-specific changes in peripheral cortisol metabolism in obese women: increased adipose 11beta-hydroxysteroid dehydrogenase type 1 activity. | Q44055207 |
| | Hypothalamic-pituitary-adrenal axis function in patients with bipolar disorder | Q44917858 |
| | Demographic and clinical characteristics of individuals in a bipolar disorder case registry | Q45027844 |
| | Hypothalamus-pituitary-adrenal system regulation and suicidal behavior in depression | Q45260809 |
| | Quality of life in patients after long-term biochemical cure of Cushing's disease. | Q45291614 |
| | A prospective investigation of the natural history of the long-term weekly symptomatic status of bipolar II disorder. | Q45931601 |
| | The long-term natural history of the weekly symptomatic status of bipolar I disorder | Q46317822 |
| | Quality-of-life impairment in depressive and anxiety disorders | Q46522380 |
| | Depressive episodes and symptoms dominate the longitudinal course of bipolar disorder | Q46919165 |
| | The dexamethasone/corticotropin-releasing hormone test in depression in bipolar and unipolar affective illness | Q48102324 |
| | Effects of acute prednisone administration on memory, attention and emotion in healthy human adults | Q48202354 |
| | Depression and inflammation: an intricate relationship | Q48793648 |
| | The association between long-term accumulation of temporary employment, the cortisol awakening response and circadian cortisol levels | Q50063339 |
| | Gastrointestinal symptoms are associated with hypothalamic-pituitary-adrenal axis suppression in healthy individuals. | Q50888298 |
| | Short telomeres in depression and the general population are associated with a hypocortisolemic state. | Q51504384 |
| | Major depression in late life is associated with both hypo- and hypercortisolemia. | Q51754162 |
| | Prednisone augmentation in treatment-resistant depression with fatigue and hypocortisolaemia: a case series. | Q54036035 |
| | Natural course and burden of bipolar disorders | Q57384100 |
| | The World Health Organization quality of life assessment (WHOQOL): Development and general psychometric properties | Q57944219 |
| | Betula: A Prospective Cohort Study on Memory, Health and Aging | Q58133667 |
| | The betula prospective cohort study: Memory, health, and aging | Q58178872 |
| | Combined dexamethasone/corticotropin-releasing hormone test in acute and remitted manic patients, in acute depression, and in normal controls: I | Q71374897 |
| | Dexamethasone for treatment of major depression in patients with bipolar disorder | Q72248879 |
| | A new self-rating scale for depression and anxiety states based on the Comprehensive Psychopathological Rating Scale | Q72322979 |
| | Dexamethasone for the treatment of depression: a randomized, placebo-controlled, double-blind trial | Q72492850 |
| | Dehydroepiandrosterone sulfate and psychiatric measures in a frail, elderly residential care population | Q73423746 |
| | Acute antidepressant effects of intravenous hydrocortisone and CRH in depressed patients: a double-blind, placebo-controlled study | Q74054724 |
| | Addison's disease presenting as depression | Q79082598 |
| | Bipolar disorder | Q80392074 |
| | Cortisol response and coping style predict quality of life in schizophrenia | Q83481377 |
| P275 | copyright license | Creative Commons Attribution 4.0 International | Q20007257 |
| P6216 | copyright status | copyrighted | Q50423863 |
| P433 | issue | 6 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | bipolar disorder | Q131755 |
| P304 | page(s) | e98682 | |
| P577 | publication date | 2014-06-16 | |
| P1433 | published in | PLOS One | Q564954 |
| P1476 | title | Relative hypo- and hypercortisolism are both associated with depression and lower quality of life in bipolar disorder: a cross-sectional study | |
| P478 | volume | 9 | |